ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-1,515 Cr | ₹-1,303 Cr | ₹-1,309 Cr | ₹-1,108 Cr | ₹-933 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ALKEM LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-1,515 Cr |
Mar2023 | ₹-1,303 Cr |
Mar2022 | ₹-1,309 Cr |
Mar2021 | ₹-1,108 Cr |
Mar2020 | ₹-933 Cr |
How is Deferred Tax Assets / Liabilities of ALKEM LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,515 Cr | Negative | |
Mar2023 | ₹-1,303 Cr | Negative | |
Mar2022 | ₹-1,309 Cr | Negative | |
Mar2021 | ₹-1,108 Cr | Negative | |
Mar2020 | ₹-933 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹60,096.6 Cr | 2.1% | -8.6% | 1.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 2.1% |
-8.6% |
1.4% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses